METHOD OF TREATING LUNG CANCER Russian patent published in 2012 - IPC A61K35/14 A61K38/20 A61P37/02 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly oncology, and may be applied in treating lung cancer. In an operation room, immediately before the introduction to general anaesthesia, blood is taken from a patient suffering lung cancer in the amount of 200-300 ml is a sterile container with a haemo-preserving agent and separated; cell mass is selected and combined with carboplatin 150 mg/m² and etoposide 100 mg/m² in a first bottle. Formed plasma is combined with rhoncoleukin 1 mil. IU, incubated at 37°C for 30 minutes in a second bottle. It is followed by the intravenous drop-by-drop introduction of the content of the first bottle, and then of the second bottle. The lung operation for the removal of a malignant growth is completed conventionally.

EFFECT: method allows avoiding side toxic responses on the introduction of the cytostatics, performing the one-stage operating removal of the malignant growth with the introduction of the anti-cancer preparations and improving body resistance, preventing postoperative complications.

4 tbl, 1 ex